Complete ICD-10-CM coding and documentation guide for Non-Small Cell Lung Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Non-Small Cell Lung Carcinoma
Malignant neoplasm of bronchus and lung
This range includes codes for primary lung cancer, including non-small cell lung carcinoma.
Large cell carcinoma
Used when histopathology specifies large cell carcinoma, a subtype of NSCLC.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when NSCLC is diagnosed without further specification of histology or laterality. |
|
M8012/3 | Large cell carcinoma | Use when histopathology specifies large cell carcinoma. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Non-Small Cell Lung Carcinoma
Use when histopathology specifies large cell carcinoma.
Ensure histology is confirmed by pathology before coding.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of other malignant neoplasm of bronchus and lung
Z85.118Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Non-Small Cell Lung Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.90.
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for reduced reimbursement.
Always document laterality in clinical notes., Verify imaging reports for laterality.
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreased accuracy in cancer registry data.
Use specific histology codes when available.
Failure to document specific histology can lead to audit issues.
Ensure pathology reports are detailed and included in patient records.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Non-Small Cell Lung Carcinoma, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Non-Small Cell Lung Carcinoma. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Non-Small Cell Lung Carcinoma? Ask your questions below.